![Fredric D. Price](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredric D. Price
Vorsitzender bei
Glycadia, Inc.
Profil
Mr. Fredric D.
Price is an Executive Chairman at Glycadia, Inc. Mr. Price was previously employed as a Founder by Fig Tree Books LLC, an Executive Chairman & Chief Executive Officer by Bioblast Pharma Ltd., an Executive Chairman by Chiasma, Inc., an Executive Chairman by Peptimmune, Inc., a Chairman by Omrix Biopharmaceuticals, Inc., a Chairman by Zymenex A/S, a Chairman & Chief Executive Officer by BioMarin Pharmaceutical, Inc., a Chief Executive Officer & Director by Applied Microbiology, Inc., a Vice President by Pfizer Pharmaceuticals, Inc., a CFO, Vice President-Administration & Finance by Regeneron Pharmaceuticals, Inc., and a Founder by RxFDP.
He also served on the board at Celsus Therapeutics Plc, Pharmasset, Inc. and Enobia Pharma, Inc. He received his undergraduate degree from Dartmouth College and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Fredric D. Price
| Unternehmen | Position | Beginn |
|---|---|---|
Glycadia, Inc.
 Glycadia, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Vorsitzender | - |
Ehemalige bekannte Positionen von Fredric D. Price
| Unternehmen | Position | Ende |
|---|---|---|
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Vorstandsvorsitzender | 31.07.2018 |
| CHIASMA, INC. | Vorsitzender | 01.01.2013 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Direktor/Vorstandsmitglied | 01.01.2012 |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Vorsitzender | 27.10.2011 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Direktor/Vorstandsmitglied | - |
Ausbildung von Fredric D. Price
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Omrix Biopharmaceuticals, Inc.
 Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Microbiology, Inc.
 Applied Microbiology, Inc. Miscellaneous Commercial ServicesCommercial Services Biological research | Commercial Services |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Glycadia, Inc.
Glycadia, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
RxFDP | |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fig Tree Books LLC
 Fig Tree Books LLC Publishing: Books/MagazinesConsumer Services Fig Tree Books LLC is a publishing company specializing in novels and non-fiction that explore the American Jewish experience. The company is located in the US. The company's catalog includes contemporary frontlist titles and a legacy collection featuring works that address themes of Jewish identity, history, trauma, culture, and societal issues. The company publishes authors such as David Hirshberg, Abigail Pogrebin, and Thane Rosenbaum, with titles ranging from historical novels and memoirs to examinations of free speech and religious dialogue. Fig Tree Books supports literary engagement through a monthly newsletter featuring short stories, essays, poetry, and excerpts relevant to the American Jewish community, and provides resources for book clubs, including discussion questions and author participation. The company's website offers information about their books, free sample chapters, author biographies, reviews, and a blog. | Consumer Services |
